Editorial Board for section 'Pharmacology'

• Anesthesiology Section
• Brain Injury Section
• Clinical Laboratory Medicine Section
• Cardiology Section
• Cardiovascular Medicine Section
• Clinical Neurology Section
• Mental Health Section
• Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine Section
• Dermatology Section
• Endocrinology & Metabolism Section
• Epidemiology & Public Health Section
• Emergency Medicine Section
• Gastroenterology & Hepatopancreatobiliary Medicine Section
• Hematology Section
• Intensive Care Section
• Immunology Section
• Infectious Diseases Section
• Nephrology & Urology Section
• Nuclear Medicine & Radiology Section
• Oncology Section
• Obstetrics & Gynecology Section
• Ophthalmology Section
• Orthopedics Section
• Otolaryngology Section
• Pharmacology Section
• Pulmonology Section
• Reproductive Medicine & Andrology Section
• Sports Medicine Section
• Dentistry, Oral Surgery and Oral Medicine Section
• Vascular Medicine Section
• General Surgery Section
• Clinical Rehabilitation Section
• Clinical Guidelines Section
• Clinical Research Methods Section
• Clinical Pediatrics Section

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.

Members

Prof. Dr. Alex Sparreboom

Prof. Dr. Alex Sparreboom

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH, USA
Interests: clinical pharmacology; pharmacokinetics; drug transporters; oncology; cancer; phase I trials; drug interactions; tyrosine kinase inhibitors; paclitaxel; OCT2, MATE1, OATP1B1; peripheral neuropathy

Prof. Dr. Andrea Tarozzi

Prof. Dr. Andrea Tarozzi

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Department for Life Quality Studies, University of Bologna, 40126 Bologna, Italy
Interests: neuroprotection; Parkinson’s disease; Huntington’s disease; neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue in Journal of Clinical Medicine: Oxidative Stress in Neurodegenerative Diseases: From Preclinical Studies to Clinical Applications
Special Issue in Journal of Clinical Medicine: Oxidative Stress in Neurodegenerative Diseases: Molecular and Cellular Mechanisms, Therapeutic Targets and Neuroprotective Strategies
Special Issue in Pharmaceuticals: Drug Candidates for the Treatment of Alzheimer’s and Parkinson’s Disease
Special Issue in Pharmaceuticals: Molecular and Cellular Studies of Natural Compounds as Potential Therapeutics in Basal Ganglia Disorders
Topics: Neuroprotection by Drugs, Nutraceuticals and Physical Activity
Topics: Neuroprotection by Drugs, Nutraceuticals and Physical Activity, 2nd Volume

Dr. Amit K. Tiwari

Dr. Amit K. Tiwari

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

College of Pharmacy, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA
Interests: drug resistance; chemotherapy failure; drug–drug interaction; anticancer drug discovery; novel mechanisms
Special Issues, Collections and Topics in MDPI journals

Special Issue in Cancers: Resistance to Apoptosis-Based Cancer Therapy—Induction of Non-apoptotic Cell Death to Overcome Chemoresistance
Special Issue in Pharmaceutics: Functionalized Nanoparticles in Cancer Therapeutics
Special Issue in Pharmaceutics: Cyclodextrins and Associated Nanomaterials for Drug and Gene Delivery
Special Issue in Pharmaceutics: Functionalized Nanoparticles in Cancer Therapeutics, 2nd Edition

Prof. Dr. Gianluca Trifirò

Prof. Dr. Gianluca Trifirò

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Department of Diagnostics and Public Health, University of Verona, Verona, Italy
Interests: pharmacoepidemiology; pharmacovigilance; healthcare research; real-world data; real-world evidence; claims database; biosimilars; biologics

Prof. Dr. Dimitrios Tsikas

Prof. Dr. Dimitrios Tsikas

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Institute of Toxicology, Core Unit Proteomics, Hannover Medical School, Hannover, Germany
Interests: nitric oxide; asymmetric dimethylarginine; homoarginine; oxidative stress; gas chromatography−mass spectrometry; bioanalytical methods development; high-performance liquid chromatography
Special Issues, Collections and Topics in MDPI journals

Special Issue in Journal of Clinical Medicine: Atherosclerosis: Endothelial Dysfunction and Beyond

Dr. Alfredo Vannacci

Dr. Alfredo Vannacci

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, 50141 Florence, Italy
Interests: pharmacovigilance; pharmacology; toxicology; pharmacoepidemiology; drug safety; clinical pharmacy; medical pharmacology
Special Issues, Collections and Topics in MDPI journals

Special Issue in Journal of Clinical Medicine: Medication Safety and Pharmacovigilance in Clinical: From the Researcher Bench to the Patient Bedside
Special Issue in Journal of Clinical Medicine: Review Special Issue Series: Recent Advances in Pharmacology

Prof. Dr. Jiabo Wang

Prof. Dr. Jiabo Wang

SciProfiles Scilit Preprints.org Google Scholar

Section Board Member

School of Traditional Chinese Medicine, Capital Medical University, Beijing, China
Interests: hepatology; metabolomics; liver fibrosis; fatty liver; liver cancer

Dr. Xiaosheng Wang

Dr. Xiaosheng Wang

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China
Interests: bioinformatics; medical genomics; cancer immunotherapy; systems biology; biostatistics

Dr. Ji-Fu Wei

Dr. Ji-Fu Wei

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China
Interests: allergy; tumor pharmacology and Individualized treatment; clinical pharmacy; molecular mechanism of tumorigenesis and development; antitumor drugs

Dr. Kai Xiao

Dr. Kai Xiao

Scilit Preprints.org Google Scholar

Website
Section Board Member

West China School of Medicine, West China Hospital of Sichuan University, Chengdu, China
Interests: cancer pharmacology, targeted drug delivery and precison oncology

Dr. Zhijie Xu

Dr. Zhijie Xu

SciProfiles Scilit Preprints.org Google Scholar

Section Board Member

Department of Pathology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, China
Interests: anti-tumor pharmacology; programmed cell death; non-coding RNA; native compounds
Special Issues, Collections and Topics in MDPI journals

Special Issue in Journal of Clinical Medicine: Clinical, Translational and Experimental Pharmacotherapeutics Advances

Dr. Ji-Ye Yin

Dr. Ji-Ye Yin

SciProfiles Scilit Preprints.org Google Scholar

Website1 Website2
Section Board Member

1. Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2. Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha 410078, China
Interests: clinical pharmacology; personalized medicine; precision medicine; pharmacogenomics; pharmacogenetics

Prof. Dr. Qinjian Zhao

Prof. Dr. Qinjian Zhao

SciProfiles Scilit Preprints.org Google Scholar

Website
Section Board Member

College of Pharmacy, Chongqing Medical University, Chongqing, China
Interests: natural metabolite-based immunomodulator research; R&D of key processes for biological preparations; quality research of biological products such as vaccines and antibodies; R&D and improvement of adjuvant preparation process and R&D of new adjuvants

Displaying Editorial board member 31-60 on page 2 of 2.

Go to page    chevron_left 1 2